A Phase II Study of Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent or Metastatic Head and Neck Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase II Study of Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent or Metastatic Head and Neck Cancer

Published:2002-01 Issue:2 Volume:14 Page:207-213
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Basaran M.,Bavbek S.E.,Güllü I.,Demirelli F.,Sakar B.,Tenekeci N.,Altun M.,Yalçin S.,ONAT H.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference15 articles.

1. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

2. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

3. Docetaxel: an active drug for squamous cell carcinoma of the head and neck.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventional treatment of keratoacanthoderma: a case report;Journal of International Medical Research;2022-12

2. Palliative chemotherapy in head and neck cancer: balancing between beneficial and adverse effects;Expert Review of Anticancer Therapy;2020-01-02

3. Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma;BMC Cancer;2016-07-13

4. A prospective study to assess the efficacy and toxicity of 5-flurouracil and cisplatin versus taxane and cisplatin as induction chemotherapy in locally advanced head and neck squamous cell cancer in a regional cancer center in India;Indian Journal of Cancer;2015

5. Taxanes in cancer of the head and neck;Anti-Cancer Drugs;2014-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3